35.1 C
New Delhi
May 24, 2024
News Bridge

Rajnath Singh Releases DRDO’s Anti-Covid19 Drug 2-DG

Defence minister Rajnath Singh on Monday released the first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19.

The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy’s Laboratories (DRL) in Hyderabad.

Speaking on the occasion, the Defence Minister congratulated DRDO and DRL, Hyderabad for manufacturing the drug that will help the COVID patients to reduce oxygen dependency and recover quickly.

“The drug is a perfect example of the country’s scientific prowess and a milestone in the efforts towards self-reliance,” reads a statement issued by the Ministry of Defence.

“2-DG drug is a new ray of hope in these challenging times,” said Rajnath Singh, expressing confidence that the medicine will play a crucial role in winning the fight against COVID-19.

The drug comes in powder form in a sachet and is taken orally by dissolving it in water, the ministry said.


Related posts

Covid19 India | ‘Full Lockdown Only Option Now’ Says Rahul Gandhi


Covid19 | India’s DCGI Exempts Post-Approval Bridging Trial For Foreign Made Vaccines


Indian Air Force To Buy 10 Anti-Drone Systems For Border Deployment


Drone Attack | India To Roll Out ‘Counter Drone Policy’ Soon: Reports


Congress Raises Instances Of Hate Speech Against Minorities In RS


J&K Grenade Attack: Girl Succumbs, Death Toll Climbs To Two


Leave a Comment